Tag: global supply chain
-
Trump Imposes 100% Tariff on China and Threatens Xi Over Rare Earths Row
Trump Announces 100% Tariff on China and Threatens Xi Talks In a bold escalation of the U.S. trade confrontation with China, President Donald Trump announced a new 100% tariff on Chinese goods to take effect from November 1. The move, framed as retaliation for what Trump called China’s “extraordinarily aggressive” export controls on rare earth…
-
Trump Warns of a ‘Hostile’ China Move on Rare Earths and Massive Tariffs
H2: Trump Decries China’s Export Controls on Rare Earths as Hostile In a post on Truth Social, former President Donald Trump characterized China’s recent move to announce export controls on rare earth elements and related materials as a “hostile” act that could disrupt global markets. Trump argued that Beijing is using letters sent to countries…
-
Rare Earths on the Frontline: China Imposes Export Controls on Production Tech
Overview: China tightens export controls on rare earth production technology China announced immediate export controls on rare earth production technology, a move that signals Beijing’s intent to safeguard its dominant position in a sector that is pivotal to advanced manufacturing. The ministry of commerce stated that exporters should strengthen compliance awareness and understand the primary…
-
China Enforces New Export Controls on Rare Earth Tech
Overview: Beijing tightens controls on rare earth production technology China, the world’s largest producer of rare earth elements, announced immediate export controls on critical production technology for rare earths. The move signals Beijing’s intent to safeguard strategic assets amid intensifying competition with the United States. The Ministry of Commerce urged exporters to bolster compliance and…
-
Trump 100% Tariffs on Drugs Shake Pharma Markets Today
Overview: Trump Announces 100% Tariffs on Drugs The White House has announced a sweeping 100% tariff on imported pharmaceuticals, to take effect starting October 1. The move is aimed at addressing what President Trump has described as an overwhelming influx of pharmaceutical products into the United States from abroad. In practice, the policy targets a…
-
Trump tariffs: Who stands to lose from new US pharma duties?
Trump’s latest tariff move arrives as a social-media surprise, with a 100% duty on branded or patented pharmaceutical products entering the United States unless manufacturers are building or planning to build US facilities. The post, made on Truth Social, did not include formal legislation, leaving industry and investors to parse what such a policy would…